Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Cancer Tumor Profiling Market Over the Coming Decade?

In recent years, the cancer tumor profiling market size has seen a substantial increase. It is anticipated to escalate from $13 billion in 2024 to $14.99 billion in 2025, marking a compound annual growth rate (CAGR) of 15.3%. Factors contributing to this growth during the historical period include a rise in cancer cases, advancements in precision medicine initiatives and collaborative research, enhanced methods for early detection and diagnostics of cancer, a broad spectrum of targeted therapy options, and favorable regulations pertaining to cancer profiling tests.

In the upcoming years, the market size for cancer tumor profiling is set to experience significant expansion, reaching $25.33 billion in 2029 with a 14.0% compound annual growth rate (CAGR). The anticipated growth during the projection period is due to factors such as the adoption and expansion of cancer treatment techniques such as immunotherapy, immunoprofiling, liquid biopsy, and non-invasive tumor profiling methods. The upsurge in the use of single-cell sequencing for thorough tumor characterization, the growth of early cancer detection and screening programs, and the growing need for profiling of rare and orphan cancer subtypes also contribute to this market expansion. The forecast period will witness several emerging trends like the incorporation of tumor profiling into regular clinical practices, advancements in multi-omics approaches, the use of artificial intelligence (AI) and machine learning for data analysis, development of personalized medicine and targeted therapies, and progress in genomics and next-generation sequencing (NGS) technologies.

Which Factors Are Enhancing the Growth of the cancer tumor profiling Market?

The global rise in cancer cases is anticipated to drive the expansion of the cancer and tumor profiling market. Cancer, a disease characterized by the unregulated growth and spread of certain cells in the body, is becoming more prevalent. This surge in cancer cases prompts an increased need for cancer tumor profiling, a tool that helps physicians assess the disease’s severity. For example, the American Cancer Society, a professional organization based in the U.S., reported an increase in new cancer cases from 1.9 million in 2023 to 2 million in 2024. Consequently, this global increase in cancer cases fuels the growth of the cancer and tumor profiling market.

Explore Comprehensive Insights Into The Global Cancer Tumor Profiling Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp

What Are the Major Players Making an Impact in the Cancer Tumor Profiling Market’s Growth?

Major companies operating in the cancer tumor profiling market include:

• F. Hoffmann-La Roche Ltd._x000D_

• Caris Life Sciences_x000D_

• Thermo Fisher Scientific Inc._x000D_

• Illumina Inc._x000D_

• Qiagen_x000D_

Which Upcoming Trends Are Set to Influence the Cancer Tumor Profiling Market’s Path Forward?

Rising research and development endeavors are becoming a prominent trend in the cancer and tumor profiling market. Major corporations in this sector are targeting these activities to cater to customer demands and strengthen their standing. Take for example, QIAGEN N.V, a German firm specializing in sample and assay technology for applied testing, pharmaceutical development, molecular diagnostics, and academic study; it recently announced the authentication and sales launch of its therascreen PIK3CA RGQ PCR Kit in Europe. This tool is of essence in identifying breast cancer patients who have PIK3CA mutations. The therascreen PIK3CA test is a diagnostic assay used to detect an activating mutation in the PIK3CA gene and is the first of its kind that allows both plasma specimens and FFPE tissue DNA testing.

Secure Your Global Cancer Tumor Profiling Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Which Key Segments of the Cancer Tumor Profiling Market Are Poised for Growth and Innovation?

The cancer tumor profiling market covered in this report is segmented –

1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies

3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types

4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

Subsegments:

1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)

2) By Breast Cancer: Hormone Receptor-Positive, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer

3) By Colorectal Cancer: Colon Cancer, Rectal Cancer

4) By Prostate Cancer: Localized Prostate Cancer, Advanced Prostate Cancer

5) By Melanoma: Cutaneous Melanoma, Non-Cutaneous Melanoma

6) By Ovarian Cancer: Epithelial Ovarian Cancer, Non-Epithelial Ovarian Cancer

7) By Stomach Cancer: Gastric Adenocarcinoma, Gastrointestinal Stromal Tumors (GISTs)

8) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Neuroendocrine Tumors

9) By Thyroid Cancer: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer

10) By Other Cancer Types: Kidney Cancer, Bladder Cancer, Liver Cancer, Esophageal Cancer

What Regions Are Steering Growth in the Cancer Tumor Profiling Sector?

North America was the largest region in cancer and tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Is the Cancer Tumor Profiling Market Classified and Defined in Market Analysis?

Cancer tumor profiling refers to a laboratory test that examines a sample of tumor tissue for specific genes, gene mutations (changes), proteins, or other biomarkers. Tumor profiling can help with treatment planning as well as predicting if cancer will recur or spread to other parts of the body.

Browse Through More Similar Reports By The Business Research Company:

Cancer Clinical Decision Tools Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report

Tumor Ablation Therapy Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: